• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内化抗原在树突状细胞中向胞质溶胶的选择性转运以进行MHC I类呈递。

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

作者信息

Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S

机构信息

Institut National de la Santé et de la Recherche Médicale U520, Institut Curie, Section de Recherche, 75005 Paris, France.

出版信息

Nat Cell Biol. 1999 Oct;1(6):362-8. doi: 10.1038/14058.

DOI:10.1038/14058
PMID:10559964
Abstract

In order for cytotoxic T cells to initiate immune responses, peptides derived from internalized antigens must be presented to the cytotoxic T cells on major histocompatibility complex (MHC) class I molecules. Here we show that dendritic cells, the only antigen-presenting cells that initiate immune responses efficiently, have developed a unique membrane transport pathway linking the lumen of endocytic compartments and the cytosol. Endosome-to-cytosol transport is restricted to dendritic cells, specific to internalized antigens and selective for the size of the transported molecules. Thus, in dendritic cells, internalized antigens gain access to the cytosolic antigen-processing machinery and to the conventional MHC class I antigen-presentation pathway.

摘要

为了使细胞毒性T细胞启动免疫反应,内化抗原衍生的肽必须在主要组织相容性复合体(MHC)I类分子上呈递给细胞毒性T细胞。我们在此表明,树突状细胞是唯一能有效启动免疫反应的抗原呈递细胞,它已形成一种独特的膜转运途径,将内吞小室的腔与细胞质连接起来。内体到细胞质的转运仅限于树突状细胞,对内化抗原具有特异性,且对转运分子的大小具有选择性。因此,在树突状细胞中,内化抗原能够进入细胞质中的抗原加工机制以及传统的MHC I类抗原呈递途径。

相似文献

1
Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.内化抗原在树突状细胞中向胞质溶胶的选择性转运以进行MHC I类呈递。
Nat Cell Biol. 1999 Oct;1(6):362-8. doi: 10.1038/14058.
2
The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.将抗原从内吞区室递送至胞质溶胶以进行交叉呈递仅限于早期未成熟树突状细胞。
Immunology. 2006 Jan;117(1):97-107. doi: 10.1111/j.1365-2567.2005.02270.x.
3
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.克隆的树突状细胞能够在主要组织相容性复合体I类和II类分子上呈递外源性抗原。
J Immunol. 1997 Mar 15;158(6):2723-30.
4
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.细菌抗原递呈系统:细菌抗原的吞噬加工,用于MHC-I和MHC-II呈递给T细胞。
Behring Inst Mitt. 1997 Feb(98):197-211.
5
Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.可溶性抗原进入内质网可以解释树突状细胞的交叉呈递现象。
Nat Immunol. 2005 Jan;6(1):107-13. doi: 10.1038/ni1147. Epub 2004 Dec 12.
6
Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane.树突状细胞成熟会触发主要组织相容性复合体II类分子从溶酶体到质膜的逆向转运。
Nature. 2002 Aug 29;418(6901):988-94. doi: 10.1038/nature01006.
7
Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.细胞外热休克蛋白 90 在将伴侣抗原从内体转运到蛋白酶体以产生抗原肽,从而由树突状细胞交叉呈递中发挥作用。
Int Immunol. 2011 Apr;23(4):223-37. doi: 10.1093/intimm/dxq475. Epub 2011 Mar 18.
8
Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.增强主要组织相容性复合体I类依赖性的经阳离子和融合肽修饰抗原的呈递。
Nat Biotechnol. 2000 Dec;18(12):1269-72. doi: 10.1038/82377.
9
Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.2型非胸腺依赖性抗原对MHC II类限制性抗原呈递的抑制作用:碳水化合物结构与抗原呈递细胞的比较分析
Cell Immunol. 1997 Feb 25;176(1):1-13. doi: 10.1006/cimm.1996.1078.
10
Efficient cross-presentation of soluble exogenous antigens introduced into dendritic cells using a weak-based amphiphilic peptide.利用一种弱碱性两亲肽,高效递呈树突状细胞内导入的可溶性外源性抗原。
Biochem Biophys Res Commun. 2010 Feb 5;392(2):217-22. doi: 10.1016/j.bbrc.2010.01.019. Epub 2010 Jan 11.

引用本文的文献

1
Cross-priming in cancer immunology and immunotherapy.癌症免疫学与免疫治疗中的交叉呈递
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
2
Efferocytosis in dendritic cells: an overlooked immunoregulatory process.树突状细胞的噬作用:一个被忽视的免疫调节过程。
Front Immunol. 2024 May 21;15:1415573. doi: 10.3389/fimmu.2024.1415573. eCollection 2024.
3
Exploiting -Primed Dendritic Cells as Potential Immunomodulators of Canine Immune Response.利用预处理的树突状细胞作为犬免疫反应的潜在免疫调节剂。
Cells. 2024 Mar 3;13(5):445. doi: 10.3390/cells13050445.
4
The evolving biology of cross-presentation.交叉呈递的生物学演变。
Semin Immunol. 2023 Mar;66:101711. doi: 10.1016/j.smim.2023.101711. Epub 2023 Jan 14.
5
Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666.树突状细胞的交叉呈递增加和使用 Arp2/3 抑制剂 CK666 增强抗肿瘤治疗。
Br J Cancer. 2023 Apr;128(6):982-991. doi: 10.1038/s41416-022-02135-4. Epub 2023 Jan 11.
6
Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.探索糖基纳米疫苗在开发交叉呈递介导的抗肿瘤免疫疗法方面的前景。
Vaccines (Basel). 2022 Nov 30;10(12):2049. doi: 10.3390/vaccines10122049.
7
Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier.肝内皮细胞持续感知 IFNα 可形成血管抗转移屏障。
Elife. 2022 Oct 25;11:e80690. doi: 10.7554/eLife.80690.
8
Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol during antigen cross-presentation.ESCRT-III 通过内吞膜修复控制抗原交叉呈递过程中向细胞质的抗原输出。
Cell Rep. 2022 Aug 16;40(7):111205. doi: 10.1016/j.celrep.2022.111205.
9
Targeted delivery to macrophages and dendritic cells by chemically modified mannose ligand-conjugated siRNA.通过化学修饰的甘露糖配体偶联的 siRNA 靶向递送至巨噬细胞和树突状细胞。
Nucleic Acids Res. 2022 May 20;50(9):4840-4859. doi: 10.1093/nar/gkac308.
10
Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.促进抗原从树突状细胞内体逃逸可增强抗肿瘤免疫。
Cell Rep Med. 2022 Feb 25;3(3):100534. doi: 10.1016/j.xcrm.2022.100534. eCollection 2022 Mar 15.